Clinical Trial News and Research

RSS

Researchers report promising Phase 1 results for first oral polio vaccine in 50 years

Before being halted due to the COVID-19 pandemic, a relentless vaccination campaign had nearly succeeded in eradicating polio from the world.

24 Apr 2020

Novotech: Many countries in Asia-Pacific are fast-tracking COVID-19 clinical trials

The Asia-Pacific's largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients' clinical trials with expedited review processes for treatment and vaccine candidates.

24 Apr 2020

Combination therapy boosts the immune system's appetite for cancer

A combination of immunotherapy agents that encourages some immune cells to eat cancer cells and alert others to attack tumors put mice with a deadly type of brain cancer called glioblastoma into long-term remission, a new study led by UT Southwestern scientists suggests.

24 Apr 2020

First COVID-19-related clinical trial to start in Germany

German regulators have approved the first clinical trial of a coronavirus vaccine. Developed by BioNTech SE, an immunotherapy company, and Pfizer, a pharmaceutical company, the potential coronavirus vaccine has completed pre-clinical studies in Germany.

24 Apr 2020

Fewer kids enroll in pediatric oncology clinical trials, study shows

Historically, pediatric cancer patients have been much more likely than adult cancer patients to enroll in clinical trials as part of their treatment.

23 Apr 2020

New clinical trial to test two drugs for prophylactic treatment of COVID-19 contact persons

With the stepwise easing of measures in Switzerland, it is pivotal to monitor for any new COVID-19 outbreaks and to contain them in a timely and effective manner.

23 Apr 2020

A faster and easier treatment option to prevent blindness in preterm infants

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently.

23 Apr 2020

Majority of women prefer LAI HIV therapy over daily pills

A new qualitative study by researchers at Columbia University Mailman School of Public Health found that the majority of women living with HIV would endorse a monthly long acting injectable (LAI) antiretroviral therapy over current daily pills.

22 Apr 2020

A first-in-human trial with promising MERS coronavirus vaccine

Over the past 20 years, coronaviruses have been responsible for large outbreaks, resulting in severe respiratory illness and a number of deaths.

22 Apr 2020

Scientists find gene signature for poor response to standard therapy in rare uterine cancer

Women who don't survive a rare and aggressive uterine cancer called uterine serous carcinoma, have high expression of a group of 73 genes, a score scientists say can help identify these women and improve their outcome.

22 Apr 2020

Convalescent plasma can be donated by COVID-19 survivors at Grifols’ donor centers

Grifols, a global healthcare company with a track record of more than 100 years and a recognized leader in the development and production of plasma-derived medicines, today announced it has begun identifying, screening and selecting volunteer donors who have recovered from COVID-19 to donate their plasma in select U.S. cities.

22 Apr 2020

Tai-Chi-based training associated with improvements in children with ADHD

Attention-deficit/hyperactivity disorder is a highly prevalent neurodevelopmental disorder affecting between 8-10 percent of school-age children.

21 Apr 2020

Study: Behavioral intervention is effective in treating language problems in youth with FXS

A UC Davis Health study found more evidence for the efficacy of telehealth-delivered behavioral intervention in treating language problems in youth with fragile X syndrome (FXS).

21 Apr 2020

A promising method to diagnose sepsis with high accuracy

Whether activating or silencing genes, breaking down defective cells or building new tissue, our body is constantly working to repair itself, even in cases of illness.

21 Apr 2020

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Convalescent plasma therapy for COVID-19 patients -- an experimental approach of giving a transfusion of plasma collected from a donor who has recovered from COVID-19 to a patient with an active infection -- is the focus of a new two-part research initiative at Penn Medicine.

20 Apr 2020

Computer simulations yield promising vaccine candidate against SARS-CoV-2

In a recent study that appeared on a preprint server bioRxiv, scientists from India designed a multi-epitope peptide-based vaccine that predicted high immunogenic response in the population.

19 Apr 2020

A promising antiviral drug to fight COVID-19 pandemic

COVID-19 patients in a clinical trial at Houston Methodist Hospital are responding quickly to the antiviral drug Remdesivir. The trial's criteria allows for the treatment of patients early in their clinical course and, in some cases, at times where they might have otherwise been intubated.

17 Apr 2020

Most Australian biotech sites are open for clinical trials, shows Novotech research

Asia-Pacific's largest specialist biotech CRO Novotech said the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations.

17 Apr 2020

UofL creates 3D-printed swab to help fill gap in COVID-19 test kits

Innovation at the University of Louisville involving multiple departments at the university has led to a promising solution for the shortage of swabs in COVID-19 test kits.

17 Apr 2020

Gimsilumab trial starts in first US patient with ARDS and COVID-19

The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.

16 Apr 2020

Clinical Trial News and Research

Researchers report promising Phase 1 results for first oral polio vaccine in 50 years

Novotech: Many countries in Asia-Pacific are fast-tracking COVID-19 clinical trials

Combination therapy boosts the immune system's appetite for cancer

First COVID-19-related clinical trial to start in Germany

Fewer kids enroll in pediatric oncology clinical trials, study shows

New clinical trial to test two drugs for prophylactic treatment of COVID-19 contact persons

A faster and easier treatment option to prevent blindness in preterm infants

Majority of women prefer LAI HIV therapy over daily pills

A first-in-human trial with promising MERS coronavirus vaccine

Scientists find gene signature for poor response to standard therapy in rare uterine cancer

Convalescent plasma can be donated by COVID-19 survivors at Grifols’ donor centers

Tai-Chi-based training associated with improvements in children with ADHD

Study: Behavioral intervention is effective in treating language problems in youth with FXS

A promising method to diagnose sepsis with high accuracy

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Computer simulations yield promising vaccine candidate against SARS-CoV-2

A promising antiviral drug to fight COVID-19 pandemic

Most Australian biotech sites are open for clinical trials, shows Novotech research

UofL creates 3D-printed swab to help fill gap in COVID-19 test kits

Gimsilumab trial starts in first US patient with ARDS and COVID-19

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer